Archean Chemical Industries Ltd

- There is no mention of any current or future fundraising through debt or equity in the call. - The company emphasizes being net debt free with a robust balance sheet. - They highlight disciplined capital allocation and healthy cash flows. - Financial strength provides strategic flexibility to invest confidently in long-term growth opportunities. - Investments in new high-potential sectors are being made from internal resources rather than external fundraising.

- Land acquisition completed for Semiconductor project in Odisha; groundwork expected to commence post-monsoon 2025. - Tendered RFQs for project management office for Semiconductor initiative last month. - Invested in Offgrid Energy Labs (zinc-bromide battery innovator) with 18.14% stake acquired; remaining commitment to be fulfilled over coming quarters. - Offgrid finalized pilot site and vendor selection for pilot plant in the U.K. - Upon successful pilot, plan to scale up to gigafactory within 18 to 24 months. - Focus on strategic investments in high-potential sectors: Bromine Derivatives, Semiconductors, and Energy Storage. - Emphasis on disciplined capital allocation backed by a robust balance sheet and net debt free status.

- **Overall Revenue Growth:** Q1 FY26 saw a 30% YoY revenue growth; steady growth expected ahead. - **Bromine Volumes:** Current run rate ~4,000 tons, aiming for 22,000 to 25,000 tons FY26 with 20-25% growth guidance; volume ramp-up expected over next quarters. - **Industrial Salt:** Maintained ~1.1 million tons sales volume with stable long-term contracts; potential for incremental volume growth. - **Sulphate of Potash (SOP):** Pilot trials successful; plant scale trials underway; meaningful contribution anticipated in H2 FY26. - **Bromine Derivatives:** Operating at 30-40% capacity; expected to cross 50% utilization by FY end; introduction of new products planned. - **Oren Hydrocarbon Business:** Targeting INR 150 crores revenue in FY26; ramp-up expected from Q3 post product certifications. - **Subsidiaries:** Derivative businesses expected to move towards PAT positivity in FY26 as ramp-up continues. - **Market Outlook:** Long-term contracts, strong customer relationships, and improving demand supporting growth confidence.

- Q1 FY26 standalone EBITDA grew 13% YoY to INR 958 million with 33% margin; consolidated net profit stood at INR 401 million. - Bromine volumes expected to grow 20-25% YoY with gradual ramp-up, supported by long-term contracts. - Industrial salt volumes stable at ~1.1 million tons; pricing resilient despite market challenges. - Sulphate of Potash (SOP) plant ramp-up underway; meaningful contribution anticipated in H2 FY26. - Bromine Derivatives currently at 30-40% capacity; expected to exceed 50% utilization by year-end, boosting margins. - Subsidiaries (Acume, Idealis) currently in loss due to ramp-up but expected to achieve PAT positivity within FY26. - Oren Hydrocarbon revenues guided INR 150 million for FY26, with sales starting Q3. - Overall growth driven by stable demand, operational efficiencies, and new product portfolios in Bromine derivatives, energy storage, and semiconductors.

- The order book for Bromine and related products is reported to be full. - The company mentioned that historically, whatever production capacity is available, they are able to sell fully. - Strong demand visibility exists for Industrial Salt, supported by long-term contracts with end customers across Asia. - For derivatives and newer businesses, the company is focused on product qualification and gaining approvals before commercial scale-up. - Demand for Bromine and salt remains robust, with customers placing orders consistently and trust in supply continuity. - Bromine Derivatives segment is gradually ramping up utilization and adding new products to the portfolio, indicating a growing order pipeline. - There is no specific numeric value disclosed for the pending orders or orderbook in the call.